ELISA Diagnostic Test Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.
An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.
Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.
ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.
Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. 'Human Factor IX Kit' is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.
Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.
In December 2022, Pictor Limited announced a new product launch of the 'PictArray SARS-CoV-2 Antibody Test,' which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.
Market Trend
Advancements in ELISA-Based Procedures
The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The 'AMP'D ELISA Signal Amplification system' is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.
Cell Signaling Technology, Inc.'s 'PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit,' designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020–2030.
Application-Based Insights
In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.
Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.
Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.
The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.
An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.
Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.
ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.
Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. 'Human Factor IX Kit' is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.
Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.
In December 2022, Pictor Limited announced a new product launch of the 'PictArray SARS-CoV-2 Antibody Test,' which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.
Market Trend
Advancements in ELISA-Based Procedures
The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The 'AMP'D ELISA Signal Amplification system' is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.
Cell Signaling Technology, Inc.'s 'PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit,' designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020–2030.
Application-Based Insights
In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.
Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.
Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.
The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 Global ELISA Diagnostic Tests Market – by Adoption
1.2.2 Global ELISA Diagnostic Tests Market – by Test Type
1.2.3 Global ELISA Diagnostic Tests Market – by Application
1.2.4 Global ELISA Diagnostic Tests Market – by End User
1.2.5 Global ELISA Diagnostic Tests Market – by Region
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ELISA DIAGNOSTIC TEST MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. ELISA DIAGNOSTIC TEST MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Infectious Diseases Among Animals
5.1.2 Increasing Incidence of Human Infections
5.2 Key Market Restraints
5.2.1 Incidents of Product Recalls
5.3 Key Market Opportunities
5.3.1 Innovative Product Launches
5.4 Future Trends
5.4.1 Advancements in ELISA-Based Procedures
6. ELISA DIAGNOSTIC TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY ADOPTION
7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
7.3 Human
7.3.1 Overview
7.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Veterinary
7.4.1 Overview
7.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Sandwich ELISA
8.3.1 Overview
8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Indirect ELISA
8.4.1 Overview
8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Competitive ELISA
8.5.1 Overview
8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Multiple & Portable ELISA
8.6.1 Overview
8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION
9.1 Overview
9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Autoimmune Diseases
9.3.1 Overview
9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Infectious Disease
9.4.1 Overview
9.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Cancer Diagnosis
9.5.1 Overview
9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Protein Quantification
9.6.1 Overview
9.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals & Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Veterinary Hospitals & Diagnostic Laboratories
10.5.1 Overview
10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11. ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – GEOGRAPHIC ANALYSIS
11.1 North America: ELISA Diagnostic Tests Market
11.1.1 Overview
11.1.2 North America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: ELISA Diagnostic Tests Market, by Country
11.1.7.1 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: ELISA Diagnostic Tests Market
11.2.1 Overview
11.2.2 Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
11.2.7.1 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: ELISA Diagnostic Tests Market
11.3.1 Overview
11.3.2 Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
11.3.7.1 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: ELISA Diagnostic Tests Market
11.4.1 Overview
11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
11.4.7.1 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: ELISA Diagnostic Tests Market
11.5.1 Overview
11.5.2 South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
11.5.7.1 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
12. ELISA DIAGNOSTICS TEST MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in ELISA diagnostics test Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Bio-Rad Laboratories Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Idexx Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott Laboratories
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Innovative Diagnostics SAS
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pictor Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DiaSorin SpA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Elabscience Biotechnology Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 SWOT Analysis
13.10.5 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 Global ELISA Diagnostic Tests Market – by Adoption
1.2.2 Global ELISA Diagnostic Tests Market – by Test Type
1.2.3 Global ELISA Diagnostic Tests Market – by Application
1.2.4 Global ELISA Diagnostic Tests Market – by End User
1.2.5 Global ELISA Diagnostic Tests Market – by Region
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ELISA DIAGNOSTIC TEST MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. ELISA DIAGNOSTIC TEST MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Infectious Diseases Among Animals
5.1.2 Increasing Incidence of Human Infections
5.2 Key Market Restraints
5.2.1 Incidents of Product Recalls
5.3 Key Market Opportunities
5.3.1 Innovative Product Launches
5.4 Future Trends
5.4.1 Advancements in ELISA-Based Procedures
6. ELISA DIAGNOSTIC TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY ADOPTION
7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
7.3 Human
7.3.1 Overview
7.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Veterinary
7.4.1 Overview
7.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Sandwich ELISA
8.3.1 Overview
8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Indirect ELISA
8.4.1 Overview
8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Competitive ELISA
8.5.1 Overview
8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Multiple & Portable ELISA
8.6.1 Overview
8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION
9.1 Overview
9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Autoimmune Diseases
9.3.1 Overview
9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Infectious Disease
9.4.1 Overview
9.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Cancer Diagnosis
9.5.1 Overview
9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Protein Quantification
9.6.1 Overview
9.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals & Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Veterinary Hospitals & Diagnostic Laboratories
10.5.1 Overview
10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11. ELISA DIAGNOSTIC TESTS MARKET – REVENUE AND FORECAST TO 2030 – GEOGRAPHIC ANALYSIS
11.1 North America: ELISA Diagnostic Tests Market
11.1.1 Overview
11.1.2 North America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: ELISA Diagnostic Tests Market, by Country
11.1.7.1 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: ELISA Diagnostic Tests Market
11.2.1 Overview
11.2.2 Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
11.2.7.1 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: ELISA Diagnostic Tests Market
11.3.1 Overview
11.3.2 Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
11.3.7.1 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: ELISA Diagnostic Tests Market
11.4.1 Overview
11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
11.4.7.1 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: ELISA Diagnostic Tests Market
11.5.1 Overview
11.5.2 South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
11.5.7.1 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
12. ELISA DIAGNOSTICS TEST MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in ELISA diagnostics test Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Bio-Rad Laboratories Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Idexx Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott Laboratories
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Innovative Diagnostics SAS
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pictor Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DiaSorin SpA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Elabscience Biotechnology Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 SWOT Analysis
13.10.5 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
